- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有401家主力机构披露2025-12-31报告期持股数据，持仓量总计2.37亿股，占流通A股56.48%
- 波段诊断：
-
技术面诊股
诊断结果：5.9技术面打败了51%的股票
技术面评分前10的股票
近期的平均成本为48.38元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为48.38元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"48.38","date":1777364435,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，明显跑赢行业平均水平。
[{"date":"2026.04.29","stock":"-2.73","trade":"0.65","ind":"1.96"},{"date":"2026.04.28","stock":"0.08","trade":"-0.61","ind":"-1.10"},{"date":"2026.04.27","stock":"0.14","trade":"0.54","ind":"0.37"},{"date":"2026.04.24","stock":"-0.98","trade":"-0.33","ind":"-0.69"},{"date":"2026.04.23","stock":"12.97","trade":"-1.30","ind":"-0.88"},{"date":"2026.04.22","stock":"0.39","trade":"0.43","ind":"1.30"},{"date":"2026.04.21","stock":"-0.20","trade":"-0.98","ind":"0.10"},{"date":"2026.04.20","stock":"0.05","trade":"-0.37","ind":"0.55"},{"date":"2026.04.17","stock":"-2.26","trade":"-1.46","ind":"0.60"},{"date":"2026.04.16","stock":"-1.33","trade":"-0.14","ind":"2.05"},{"date":"2026.04.15","stock":"1.85","trade":"2.24","ind":"-0.97"},{"date":"2026.04.14","stock":"2.91","trade":"0.68","ind":"1.61"},{"date":"2026.04.13","stock":"-1.47","trade":"-0.85","ind":"0.69"},{"date":"2026.04.10","stock":"0.32","trade":"0.52","ind":"2.24"},{"date":"2026.04.09","stock":"-2.22","trade":"-2.18","ind":"-0.33"},{"date":"2026.04.08","stock":"1.42","trade":"1.06","ind":"4.79"},{"date":"2026.04.07","stock":"0.68","trade":"0.46","ind":"0.36"},{"date":"2026.04.03","stock":"-3.39","trade":"-2.72","ind":"-0.99"},{"date":"2026.04.02","stock":"-0.31","trade":"1.12","ind":"-1.60"},{"date":"2026.04.01","stock":"5.21","trade":"4.62","ind":"1.70"},{"date":"2026.03.31","stock":"-1.00","trade":"-0.68","ind":"-1.81"}]
贝达药业,深证成指,化学制药指数
压力支撑
该股压力位为48.43元，支撑位为47.65元。
[{"text":"\u538b\u529b\u4f4d","value":"48.43","date":1777392000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"47.65","date":1777392000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.6资金面打败了89%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月29日 17:36
| 机构今日流向(万元) | 506.28 | 机构5日流向(万元) | -4393.42 |
| 机构10日流向(万元) | -14811.32 | 机构20日流向(万元) | -20933.56 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加509.02万股，其中基金净减仓82家，主力净减仓135家，暂未发现中长期投资价值。
截止2025-12-31，共401家主力机构（基金396家，一般法人5家），持仓量总计23686.36万股，占流通A股56.48%
其中，基金持仓与2025-06-30相比：
增仓：69家 ，增持 515.72万股
减仓：151家 ，减持 963.59万股
新出现在主力名单中：155家 ，持有3289.44万股
从主力名单中消失：290家 ，原持有2332.55万股
其中，基金持仓与2025-06-30相比：
增仓：69家 ，增持 515.72万股
减仓：151家 ，减持 963.59万股
新出现在主力名单中：155家 ，持有3289.44万股
从主力名单中消失：290家 ，原持有2332.55万股
消息面诊股
诊断结果：6消息面打败了66%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 聚力创新药生态，同创伟业携手成员企业“ 走进贝达药
2026-04-29 - 贝达药业：4月28日获融资买入7006.94万元
2026-04-29 - 贝达药业：4月27日持仓该股ETF资金净流出315
2026-04-28 - 贝达药业：4月27日获融资买入8205.01万元
2026-04-28 - 深化产融合作 共筑健康未来 | 杭州银行与贝达药业
2026-04-27 - 15款药物交锋四大靶点：代际演进如何重塑肺癌小分子
2026-04-27 - 券商观点|医药生物行业双周报：第六批耗材国采即将执
2026-04-27 - 恒瑞、贝达、百济神州、阿斯利康等巨头高管变动，一季
2026-04-27 - 一季报亮眼却迎高层变动，贝达药业宣布董秘辞职，公司
2026-04-27 - 贝达药业：4月24日持仓该股ETF资金净流出135
2026-04-27
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-27 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-23 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2026-04-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-02 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-01-09 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-27 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-09-10 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-20 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：1.9行业面打败了17%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.04.29","price":"1.96","value":"0.65"},{"date":"2026.04.28","price":"-1.10","value":"-0.61"},{"date":"2026.04.27","price":"0.37","value":"0.54"},{"date":"2026.04.24","price":"-0.69","value":"-0.33"},{"date":"2026.04.23","price":"-0.88","value":"-1.30"},{"date":"2026.04.22","price":"1.30","value":"0.43"},{"date":"2026.04.21","price":"0.10","value":"-0.98"},{"date":"2026.04.20","price":"0.55","value":"-0.37"},{"date":"2026.04.17","price":"0.60","value":"-1.46"},{"date":"2026.04.16","price":"2.05","value":"-0.14"},{"date":"2026.04.15","price":"-0.97","value":"2.24"},{"date":"2026.04.14","price":"1.61","value":"0.68"},{"date":"2026.04.13","price":"0.69","value":"-0.85"},{"date":"2026.04.10","price":"2.24","value":"0.52"},{"date":"2026.04.09","price":"-0.33","value":"-2.18"},{"date":"2026.04.08","price":"4.79","value":"1.06"},{"date":"2026.04.07","price":"0.36","value":"0.46"},{"date":"2026.04.03","price":"-0.99","value":"-2.72"},{"date":"2026.04.02","price":"-1.60","value":"1.12"},{"date":"2026.04.01","price":"1.70","value":"4.62"},{"date":"2026.03.31","price":"-1.81","value":"-0.68"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 美诺华 | 59.66% | 29.31% | 6.2分 |
| 2 | 纳微科技 | 31.00% | -1.85% | 5.5分 |
| 3 | 多瑞医药 | 30.95% | 6.15% | 5.7分 |
| 4 | 莱美药业 | 28.80% | 0.63% | 5.3分 |
| 5 | 通化金马 | 23.55% | 0.80% | 5.5分 |
| 6 | 一品红 | 22.79% | 11.63% | 5.9分 |
| 8 | 共同药业 | 18.64% | 14.72% | 5.8分 |
| 10 | 汇宇制药 | 16.83% | 0.98% | 5.1分 |
| 12 | 金石亚药 | 14.24% | 10.45% | 5.6分 |
| 14 | 悦康药业 | 12.49% | -2.68% | 4.7分 |
| 16 | 宏源药业 | 12.03% | 8.28% | 6.5分 |
| 18 | 前沿生物 | 11.35% | 7.65% | 5.2分 |
| 20 | 翰宇药业 | 11.12% | -7.04% | 4.8分 |
| 22 | 司太立 | 10.49% | 10.39% | 5.7分 |
| 24 | 罗欣药业 | 10.45% | 5.27% | 5.9分 |
| 26 | - | 9.78% | 0.37% | 分 |
| 28 | 富祥药业 | 9.26% | 8.12% | 5.7分 |
| 30 | 昂利康 | 7.76% | -14.10% | 5.0分 |
| 32 | 键凯科技 | 7.44% | -8.66% | 5.3分 |
| 34 | 海欣股份 | 6.89% | -0.83% | 5.7分 |
| 36 | 科源制药 | 6.67% | -3.73% | 5.3分 |
| 38 | 华纳药厂 | 5.86% | 0.62% | 5.0分 |
| 40 | 首药控股 | 5.24% | 1.53% | 5.0分 |
| 42 | 普洛药业 | 5.00% | 1.71% | 5.4分 |
| 44 | 赛托生物 | 4.88% | 7.93% | 6.4分 |
| 46 | - | 4.81% | -3.76% | 分 |
| 48 | 哈药股份 | 4.55% | -6.36% | 4.7分 |
| 50 | 微芯生物 | 4.06% | -4.16% | 5.0分 |
| 52 | 誉衡药业 | 4.02% | -3.47% | 5.4分 |
| 54 | 奥赛康 | 3.51% | -0.80% | 5.9分 |
| 56 | 德展健康 | 2.84% | 8.71% | 4.9分 |
| 58 | 海思科 | 2.30% | -4.90% | 5.7分 |
| 60 | 金陵药业 | 1.95% | -5.18% | 5.2分 |
| 62 | 西点药业 | 1.54% | 4.56% | 6.1分 |
| 64 | - | 1.44% | -5.79% | 分 |
| 66 | 福安药业 | 1.22% | 0.24% | 5.3分 |
| 68 | 百济神州 | 1.16% | -2.02% | 4.7分 |
| 70 | 诚意药业 | 1.01% | 2.22% | 5.9分 |
| 72 | *ST惠程 | 0.48% | -4.76% | 4.9分 |
| 74 | 广济药业 | 0.28% | 9.00% | 5.6分 |
| 76 | 恩华药业 | 0.04% | 4.28% | 5.5分 |
| 78 | 华海药业 | -0.37% | -1.78% | 5.0分 |
| 80 | 天新药业 | -0.53% | -0.38% | 5.5分 |
| 82 | 健康元 | -0.89% | 1.46% | 5.3分 |
| 84 | 灵康药业 | -1.09% | 3.41% | 5.7分 |
| 86 | 丰原药业 | -1.37% | -0.31% | 5.7分 |
| 88 | 科伦药业 | -1.70% | 0.71% | 5.1分 |
| 90 | 哈三联 | -2.04% | 5.77% | 5.4分 |
| 92 | 易明医药 | -2.16% | -5.47% | 5.4分 |
| 94 | 百利天恒 | -2.52% | -8.27% | 4.9分 |
| 96 | 仙琚制药 | -2.76% | -1.45% | 5.1分 |
| 98 | 神奇制药 | -2.98% | 0.34% | 5.9分 |
| 100 | 华润双鹤 | -3.28% | -0.94% | 5.2分 |
| 102 | - | -3.44% | -8.02% | 分 |
| 104 | 健友股份 | -3.58% | 0.11% | 5.2分 |
| 106 | 北陆药业 | -3.70% | -1.73% | 5.1分 |
| 108 | 新华制药 | -4.17% | -1.66% | 5.0分 |
| 110 | 永安药业 | -4.27% | -1.12% | 5.0分 |
| 112 | 同和药业 | -4.66% | -2.14% | 5.5分 |
| 114 | 奥翔药业 | -4.74% | -3.50% | 4.6分 |
| 116 | 华邦健康 | -4.78% | -5.14% | 4.7分 |
| 118 | 亨迪药业 | -4.90% | -2.97% | 5.0分 |
| 120 | 拓新药业 | -4.98% | -3.53% | 3.8分 |
| 122 | 华东医药 | -5.04% | -1.81% | 5.5分 |
| 124 | ST复华 | -5.17% | 1.15% | 4.2分 |
| 126 | 东诚药业 | -5.40% | -3.90% | 4.5分 |
| 128 | 立方制药 | -5.69% | -4.74% | 5.6分 |
| 130 | 富士莱 | -5.89% | -7.09% | 5.1分 |
| 132 | 国邦医药 | -6.81% | 0.37% | 6.0分 |
| 134 | 东北制药 | -6.94% | -3.13% | 4.5分 |
| 136 | 千红制药 | -7.20% | -7.44% | 4.2分 |
| 138 | 川宁生物 | -7.31% | -1.81% | 4.8分 |
| 140 | 海翔药业 | -7.45% | -6.67% | 5.3分 |
| 142 | 华特达因 | -8.18% | -5.07% | 4.9分 |
| 144 | 海南海药 | -8.82% | -6.59% | 4.1分 |
| 146 | 国药现代 | -9.52% | -1.64% | 5.5分 |
| 148 | 双鹭药业 | -11.07% | -8.29% | 4.1分 |
| 150 | 亿帆医药 | -11.36% | -6.49% | 4.5分 |
| 152 | 力生制药 | -12.54% | -9.87% | 4.6分 |
| 154 | 信立泰 | -15.35% | -9.09% | 5.1分 |
| 156 | 能特科技 | -15.96% | -1.06% | 4.7分 |
| 158 | 奥锐特 | -21.74% | -13.92% | 4.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 25/220 ， 17/220。
[{"date":"2026-03-31","value":"3.52","vol":"0.77"},{"date":"2025-12-31","value":"5.02","vol":"-1.77"},{"date":"2025-09-30","value":"5.55","vol":"1.53"},{"date":"2025-06-30","value":"2.51","vol":"1.23"},{"date":"2025-03-31","value":"1.80","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.52 | 5.02 | 5.55 | 2.51 | 1.80 |
| 行业(%) | 0.77 | -1.77 | 1.53 | 1.23 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"79.08","vol":"50.92"},{"date":"2025-12-31","value":"79.53","vol":"50.40"},{"date":"2025-09-30","value":"80.34","vol":"49.60"},{"date":"2025-06-30","value":"81.18","vol":"49.57"},{"date":"2025-03-31","value":"81.28","vol":"49.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
79.08 | 79.53 | 80.34 | 81.18 | 81.28 |
| 行业(%) | 50.92 | 50.40 | 49.60 | 49.57 | 49.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 31/220 ， 14/220。
[{"date":"2026-03-31","value":"13.33","vol":"27.14"},{"date":"2025-12-31","value":"24.81","vol":"40.78"},{"date":"2025-09-30","value":"15.90","vol":"141.64"},{"date":"2025-06-30","value":"15.37","vol":"78.57"},{"date":"2025-03-31","value":"24.71","vol":"0.03"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
13.33 | 24.81 | 15.90 | 15.37 | 24.71 |
| 行业(%) | 27.14 | 40.78 | 141.64 | 78.57 | 0.03 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"135.71","vol":"48.38"},{"date":"2025-12-31","value":"-24.15","vol":"-25.34"},{"date":"2025-09-30","value":"-23.86","vol":"-2.93"},{"date":"2025-06-30","value":"-37.53","vol":"58.23"},{"date":"2025-03-31","value":"1.99","vol":"-10.52"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
135.71 | -24.15 | -23.86 | -37.53 | 1.99 |
| 行业(%) | 48.38 | -25.34 | -2.93 | 58.23 | -10.52 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 63/220 ， 57/220。
[{"date":"2026-03-31","value":"0.10","vol":"0.11"},{"date":"2025-12-31","value":"0.36","vol":"0.41"},{"date":"2025-09-30","value":"0.29","vol":"0.31"},{"date":"2025-06-30","value":"0.19","vol":"0.21"},{"date":"2025-03-31","value":"0.10","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.36 | 0.29 | 0.19 | 0.10 |
| 行业(次) | 0.11 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.59","vol":"0.66"},{"date":"2025-12-31","value":"2.20","vol":"2.61"},{"date":"2025-09-30","value":"1.66","vol":"1.93"},{"date":"2025-06-30","value":"1.05","vol":"1.29"},{"date":"2025-03-31","value":"0.58","vol":"0.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.59 | 2.20 | 1.66 | 1.05 | 0.58 |
| 行业(次) | 0.66 | 2.61 | 1.93 | 1.29 | 0.65 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"25.35","vol":"-2.19"},{"date":"2025-12-31","value":"27.22","vol":"14.28"},{"date":"2025-09-30","value":"22.66","vol":"4.27"},{"date":"2025-06-30","value":"18.12","vol":"2.95"},{"date":"2025-03-31","value":"32.43","vol":"-26.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 25.35 | 27.22 | 22.66 | 18.12 | 32.43 |
| 行业 | -2.19 | 14.28 | 4.27 | 2.95 | -26.34 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.12","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.44","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.12 | - | 1.44 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 66/220 ， 35/220。
[{"date":"2026-03-31","value":"0.99","vol":"3.67"},{"date":"2025-12-31","value":"0.82","vol":"3.34"},{"date":"2025-09-30","value":"0.77","vol":"3.48"},{"date":"2025-06-30","value":"0.77","vol":"3.66"},{"date":"2025-03-31","value":"0.62","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.99 | 0.82 | 0.77 | 0.77 | 0.62 |
| 行业 | 3.67 | 3.34 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.62","vol":"3.02"},{"date":"2025-12-31","value":"0.48","vol":"2.72"},{"date":"2025-09-30","value":"0.44","vol":"2.73"},{"date":"2025-06-30","value":"0.45","vol":"2.88"},{"date":"2025-03-31","value":"0.36","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.62 | 0.48 | 0.44 | 0.45 | 0.36 |
| 行业 | 3.02 | 2.72 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 38/220 ， 51/220。
[{"date":"2026-03-31","value":"35.79","vol":"32.56"},{"date":"2025-12-31","value":"36.89","vol":"34.23"},{"date":"2025-09-30","value":"38.97","vol":"34.05"},{"date":"2025-06-30","value":"38.28","vol":"34.11"},{"date":"2025-03-31","value":"38.29","vol":"34.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
35.79 | 36.89 | 38.97 | 38.28 | 38.29 |
| 行业(%) | 32.56 | 34.23 | 34.05 | 34.11 | 34.08 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.56","vol":"10.89"},{"date":"2025-12-31","value":"0.59","vol":"1.81"},{"date":"2025-09-30","value":"0.65","vol":"1.19"},{"date":"2025-06-30","value":"0.63","vol":"0.87"},{"date":"2025-03-31","value":"0.63","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.56 | 0.59 | 0.65 | 0.63 | 0.63 |
| 行业(%) | 10.89 | 1.81 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"1.45","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.48","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.03","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.05","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"7.33","blueLineValue":"1.74","type":"YC"}]